BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $307

Moomoo NewsSep 27 06:33 ET · Ratings

Looking Into Alnylam Pharmaceuticals's Recent Short Interest

BenzingaSep 26 12:15 ET

Alnylam to Webcast TTR Investor Day

BusinesswireSep 26 08:00 ET

China Merchants Initiates Alnylam Pharmaceuticals at Buy With $360 Price Target

MT NewswiresSep 20 11:36 ET · Ratings

Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says

MT NewswiresSep 19 15:43 ET

BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating

Moomoo NewsSep 16 09:32 ET · Ratings